The agency highlighted risks including dosing errors, contamination, and the use of unapproved salt forms in compounded versions, some of which resulted in adverse events requiring hospitalizations.[3] This followed previous statements by the FDA concerning unapproved GLP-1 drugs used for weight loss, including concerns with compounded versions of the drug, fraudulent compounded GLP-1 drugs, and versions sold falsely for research purposes or not for human consumption.[4] Import Alert 66-80 now ties enforcement to the Green List by authorizing detention without physical examination of GLP-1 API shipments from non-listed firms
Tirzepatide works by activating both GIP and GLP-1 receptors
Compounded Medication Risks : Compounded GLP-1s are not FDA-approved, which may concern some users
Deficiency can leave you feeling tired and fatigued
I haven't gotten into, like, the
That's one area where doctors see at least some rationale, even though research on alternative dosing strategies remains limited